Nasdaq Net Change Percentage Gainers & Losers

Dow Jones
14 Mar
GAINERS
COMPANYSYMBOLLASTCHANGEPERCENTVOLUME
------------------------------------
Aveanna HealthcareAVAH5.141.4037.433,397,097
EW Scripps CoSSP2.730.6833.178,948,816
QuantumQMCO14.823.5631.624,111,585
GrShr 2x Long INTC DailyINTW25.605.7528.97943,072
MeiraGTx HoldingsMGTX8.251.8428.716,294,208
Amber International ADRAMBR11.001.7619.05288,237
Bowen AcquisitionBOWN4.360.6617.716,397
FreightCar AmericaRAIL7.321.0917.501,196,268
Atlantic InternationalATLN6.000.8616.7372,940
First Finl NorthwestFFNW22.643.0915.81264,138
LOSERS
COMPANYSYMBOLLASTCHANGEPERCENTVOLUME
------------------------------------
FSTKBSX2.21-0.89-28.7174,734
BioteBTMD3.07-1.03-25.121,599,954
iRobotIRBT3.06-1.01-24.758,018,784
Advanced Flower CapitalAFCG6.76-1.73-20.381,084,162
Defiance Dly Target 2X LgSMCX44.91-8.47-15.873,191,743
GrShr 2x Long SMCI DailySMCL16.58-3.08-15.67764,297
Phathom PharmaceuticalsPHAT4.22-0.78-15.601,422,074
GrShr 2x Long MARA DailyMRAL15.36-2.72-15.0421,701
ZynexZYXI2.91-0.51-14.811,323,661
GrShr 2x Long COIN DailyCONL15.20-2.61-14.659,010,555
Only includes stocks with a prior day close of $2 a share
or higher and at least 2,000 shares traded today.
Data are delayed at least 15 minutes.
Source: WSJ Market Data Group

(END) Dow Jones Newswires

March 13, 2025 17:44 ET (21:44 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10